SageView Advisory Group’s Aurora Cannabis ACB Stock Holding History

SageView Advisory Group’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$47	–	597
2025 Q4	$47	Buy	+11	New	+$54	﹤0.01%	2569

Other funds holding ACB

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

SageView Advisory Group's ACB Position: Q1 2026 in Review

SageView Advisory Group sold out of Aurora Cannabis (ACB) in Q1 2026, closing a stake of 11 shares — an estimated $47 sold.

SageView Advisory Group first reported a position in ACB in Q4 2025 and held it in 1 quarter. The position peaked at $47 in Q4 2025. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

SageView Advisory Group reported no remaining Aurora Cannabis position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 11 Aurora Cannabis shares in Q1 2026, an estimated $47.
SageView Advisory Group first reported a position in Aurora Cannabis in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Aurora Cannabis position peaked at $47 in Q4 2025.
155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.